Closing the Cervical Cancer Screening Gap

MedInno combines affordable HPV testing, portable extraction platforms, and community-based screening models to enable earlier detection of cervical cancer in underserved and low-resource settings.

Partner With Us
OVERVIEW

Cervical Cancer Remains a Preventable Crisis

Cervical cancer is almost entirely preventable through HPV testing, yet it still kills a woman every two minutes because screening never reaches her.

660K

New Cases Per Year

350K

Deaths Per Year

85%+

Unscreened In LMICs

THE MEDINNO APPROACH

A scalable workflow designed to reduce the cost of population-wide testing

SCREENING WORKFLOW

Geographic Mapping

We map districts with low cervical screening coverage, directing mobile camps to the blocks where women have never been tested

SCREENING WORKFLOW

Community Mobilization

Community health workers and ASHA networks counsel women and register them for point-of-care HPV testing camps.

SCREENING WORKFLOW

Sample Collection

A simple self-collected or clinician-collected vaginal swab replaces the need for a full pelvic speculum exam.

SCREENING WORKFLOW

Rapid Molecular Testing

Samples are processed on portable Real-Time PCR platforms, delivering high-risk HPV results within hours, not weeks.

SCREENING WORKFLOW

Treatment Linkage & Reporting

Positive cases are logged on our digital dashboard and linked directly to colposcopy and treatment centres.

Technology

Screening Technology Beyond Labs

MedInno's molecular platforms are engineered for heat, dust, and unreliable power, so accurate HPV testing works as well in a village camp as in a city lab.

Nucleic Acid Extraction

Our low-cost extraction kits isolate HPV DNA from a single swab without cold storage or specialised lab technicians.

Targeted Real-Time PCR

Purpose-built assays detect high-risk HPV genotypes in one run, cutting diagnosis time from weeks to hours.

Field-Ready Infrastructure

Battery-powered instruments and rugged carry cases keep screening camps operational through power cuts and travel.

Impact On Systems

Greater Rural Reach

Decentralised testing brings cervical cancer screening to sub-district health posts, cutting travel time for women in remote areas.

Impact On Systems

Faster Case Notification

Same-day results mean women receive their status before they leave the camp, instead of weeks later by post.

Impact On Systems

Reduced Loss to Follow-Up

Immediate result delivery reduces the loss to follow-up that lets precancerous lesions progress to invasive cervical cancer.

FOR LOW-RESOURCE SETTINGS

Designed for gaps in standard diagnostic systems.

Metropolitan labs assume constant electricity, sterile clinical counters, and advanced laboratory engineers. Remote blocks present real structural barriers: spotty power, extreme heat, unpaved terrain, and diagnostic resource shortages.

MedInno systematically optimizes molecular reagents to maintain thermal tolerance, packages workflows inside portable rugged travel cases, and optimizes software for offline-sync data logging.
Collaboration

Mass screening is most effective as a public-health effort.

Government Health Departments Public Health & Multilateral Bodies NGOs & Global Health Foundations CSR & Corporate Partners
icon

Government Health Departments

State health departments rely on MedInno to extend cervical screening beyond district hospitals into block-level camps, supporting national cervical cancer elimination targets without new permanent lab infrastructure.

icon

Public Health & Multilateral Bodies

Public health bodies use MedInno's field data to track screening coverage and direct funding toward the districts with the lowest screening rates.

icon

NGOs & Global Health Foundations

NGOs running women's health drives pair our portable kits with community health workers, reaching tea gardens, tribal belts, and informal settlements that clinics rarely cover.

icon

CSR & Corporate Partners

Corporate CSR programmes fund cervical screening camps for women employees and surrounding communities, combining compliance with measurable public-health impact.

Partner With Us to Advance Cervical Cancer Prevention

MedInno collaborates with health ministries, NGOs, hospitals and screening programmes to strengthen access to HPV testing and support earlier identification of women who may require follow-up.

Get In Touch